Bicalutamide and Raloxifene Hydrochloride in Treating Patients With Prostate Cancer Undergoing Surgery
Conditions: Stage I Prostate Adenocarcinoma; Stage II Prostate Adenocarcinoma Interventions: Drug: Bicalutamide; Other: Laboratory Biomarker Analysis; Other: Questionnaire Administration; Drug: Raloxifene Hydrochloride Sponsors: Mayo Clinic; National Cancer Institute (NCI) Not yet recruiting - verified May 2017
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials